Haematologic Technologies, LLC

Essex, VT Doing business as Prolytix

UEI
NBRNPENP8AG9
CAGE
3FYT9
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
57 River Rd #1021, Essex Junction, VT 05452, USA
Website
goprolytix.com
Founded
1987
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Custom collection tubes W81XWH14P0010 Medical Command (Army) $20,080
Stability study W81XWH13P0518 Medical Command (Army) $17,100
Custom collection tubes #scat-144-4.5/5 W81XWH13P0450 Medical Command (Army) $4,300
Corn trypsin inbibitor 5MG/ML, CTI-01 W81XWH13P0375 Medical Command (Army) $11,450
Inhibitor, corn trypsin 1 MG (5MG/ML) W81XWH13P0005 Medical Command (Army) $12,900

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Development of an enhanced, simplified blood coagulation test to monitor patients on direct oral anti-coagulants R43HL144261 National Heart Lung and Blood Institute (NIH) $154,143
A global test of hemostatic risk R42HL076904 National Institutes of Health $350,951

SBA capabilities narrative

From the vendor's SBA profile

Manufacturers of high-quality coagulation proteins and reagents for research use. HTI also performs contract coagulation research, and protein purification and modification.

Quick answers

Is Haematologic Technologies, LLC registered in SAM.gov?

Yes. Haematologic Technologies, LLC's SAM.gov registration is active through March 6, 2027.

What is Haematologic Technologies, LLC's most recent federal award?

Haematologic Technologies, LLC's most recent federal grant award is Development of an enhanced, simplified blood coagulation test to monitor patients on direct oral anti-coagulants (R43HL144261), from National Heart Lung and Blood Institute (NIH), on July 15, 2018.

On GovTribe

See Haematologic Technologies, LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login